COVID-19 Treatment Services

Monoclonal Antibody Infusion


Phoenix ER & Medical Hospital is now offering monoclonal antibody infusions for patients with an active mild to moderate COVID-19 infection to prevent progression to severe disease.

We offer both:

  • Regen-COV (Casirivimab/Imdevimab) Monoclonal Antibody Infusions
  • Bamlanivimab/Etesevimab Monoclonal Antibody Infusions

This treatment is for patients 12 years or older who weigh more than 88lbs, have tested positive for COVID-19, are within 10 days of onset symptoms, and have at least one high-risk factor for severe outcomes with infection.

Examples of high-risk factors include but are not limited to:

  • Age > or equal to 65 years
  • Diabetes
  • Cardiovascular diseases (including high blood pressure)
  • Chronic kidney disease
  • Obesity

Total infusion time can take up to four hours. This includes monitoring the patient for one hour post infusion completion.


These infusions are generally well-tolerated, but they are only emergency use approved. They are not fully FDA-approved. Patients are required to receive a fact sheet to read over before receiving the infusion. Please see below:

Regen-COV (Casirivimab/Imdevimab)

Fact Sheet



Fact Sheet